Abstract
Exposure to intimate partner violence (IPV), including physical, sexual, and psychological violence, aggression, and/or stalking, impacts overall health and can have lasting mental and physical health consequences. Substance misuse is common among individuals exposed to IPV, and IPV-exposed women (IPV-EW) are at-risk for transitioning from substance misuse to substance use disorder (SUD) and demonstrate greater SUD symptom severity; this too can have lasting mental and physical health consequences. Moreover, brain injury is highly prevalent in IPV-EW and is also associated with risk of substance misuse and SUD. Substance misuse, mental health diagnoses, and brain injury, which are highly comorbid, can increase risk of revictimization. Determining the interaction between these factors on the health outcomes and quality of life of IPV-EW remains a critical need. This narrative review uses a multidisciplinary perspective to foster further discussion and research in this area by examining how substance use patterns can cloud identification of and treatment for brain injury and IPV. We draw on past research and the knowledge of our multidisciplinary team of researchers to provide recommendations to facilitate access to resources and treatment strategies and highlight intervention strategies capable of addressing the varied and complex needs of IPV-EW.
1. Introduction
It is estimated that one in three women worldwide experiences physical and/or sexual violence from an intimate partner (Devries et al., 2013; Breiding et al., 2014; WHO, 2021). Intimate partner violence-exposed women (IPV-EW) frequently experience negative psychological (Campbell, 2002; Afifi et al., 2009; Fletcher, 2010; Okuda et al., 2011; Brignone et al., 2018; Iovine-Wong et al., 2019) and physiological (Campbell, 2002; Wuest et al., 2008, 2010; Kwako et al., 2011) symptoms, as well as comorbidities such as depression, anxiety, posttraumatic stress disorder (PTSD; Dardis et al., 2021), and suicidal ideation (Alhusen et al., 2015; Brignone et al., 2018; Iovine-Wong et al., 2019; Rasmussen et al., 2021). Substance misuse is also seen after IPV exposure in women (Testa et al., 2003; Pallatino et al., 2019; Ogden et al., 2022). Furthermore, the physical and sexual trauma that often occurs in IPV increases the risk for bodily injuries that can result in chronic pain, as well as head, neck, and/or facial injuries that can cause traumatic brain injury (TBI) or acquired hypoxic–ischemic brain injury as a result of non-fatal strangulation (NFS) or other forms of impeded breathing (Wilbur et al., 2001; Valera and Berenbaum, 2003; Wuest et al., 2008; St Ivany and Schminkey, 2016; Campbell et al., 2022; Walker et al., 2022)1. Large independent literatures have identified interrelationships between IPV exposure history and mental health diagnoses, chronic pain, brain injury, substance misuse, and substance use disorder (SUD; Merkel et al., 2017; Voon et al., 2018; Lutgendorf, 2019; Stone and Rothman, 2019; Campbell et al., 2022; Haag et al., 2022; Ogden et al., 2022; Oram et al., 2022); yet, few studies have attempted to piece together the complex interactions between these variables in a manner that supports frontline clinical strategies that more holistically bolster the quality of life for IPV-EW.
This narrative review begins this process by providing a broad framework for understanding substance use and misuse in IPV-EW to researchers and frontline clinicians. IPV and mental health comorbidities have been thoroughly discussed in the literature (Campbell, 2002; Afifi et al., 2009; Okuda et al., 2011; Brignone et al., 2018), and the varied and complex interplay of these factors on risk of substance misuse and SUD warrants a targeted discussion. Despite the elevated risk for substance misuse and SUD associated with IPV, the causal pathways from IPV to SUD and the interaction between IPV exposure and comorbid mental health diagnoses, pain, and brain injury is not clearly understood. This dearth of research exploring mediating factors in the relationship between IPV and SUD interferes with the development of new treatment targets and improvement of clinical outcomes for IPV-EW. Moreover, it perpetuates common stigmas associated with substance misuse, including the identification of substance users as intractable, “difficult” to treat, and even incurable.
2. The relationship of substance use and IPV exposure
Substance misuse is defined as substance use at high doses or in inappropriate situations. SUD is a diagnosable illness that arises following prolonged substance misuse and that significantly alters health and daily functioning (Campbell, 2002; McLellan, 2017). Substance misuse in IPV-EW has been reported as a means of coping with the physical and emotional pain (Smith et al., 2012; Simonelli et al., 2014; Gezinski et al., 2021). Self-medication, defined in the general population as using alcohol, recreational drugs with analgesic properties, and prescription opioids to treat pain (Alford et al., 2016; Cil et al., 2019; Rogozea et al., 2020), can accelerate the progression from substance use to SUD (Timko et al., 2005; Lehavot et al., 2014; Hogarth et al., 2019); however, the use of psychoactive substances as self-medication is not specific to the IPV community - it is a common pathway to addiction across populations. Moreover, similar to research in other fields that links heavy and frequent use of psychoactive substances to risk of violence and assault, substance misuse and SUD has been shown to also place IPV-EW at an increased risk for future IPV victimization (Kingery et al., 1992; Kilpatrick et al., 1997; Cunningham et al., 2009).
IPV exposure in women may increase the occurrence of risky substance use behaviors. For example, frequent patterns of heavy or binge drinking episodes (Testa and Leonard, 2001; Martino et al., 2005; Weinsheimer et al., 2005; Hink et al., 2015; Ullman and Sigurvinsdottir, 2015) and drinking and driving (Hanson, 2010) have been observed. Elevated rates of illicit substance use (El-Bassel et al., 2005; Gilbert et al., 2012; Hink et al., 2015), misuse of prescription medications (Smith et al., 2012; Hall et al., 2016), and needle sharing for intravenous substance use (Braitstein et al., 2003; Wagner et al., 2009) have also been reported in women exposed to physical or sexual violence relative to non IPV-EW. These risky behaviors contribute to general poor health and increased mortality, even in circumstances where they do not reach criteria for a SUD diagnosis (Patel et al., 2016; Dwyer-Lindgren et al., 2018; Gjersing and Bretteville-Jensen, 2018). For instance, intravenous substance use increases the risk for contracting highly communicable diseases like hepatitis C and human immunodeficiency virus (HIV) as well as other infections (Lake and Kennedy, 2016). In addition, misuse of prescription medications and illicit substances is associated with greater risk of chronic illnesses like pulmonary complications and liver failure (Baltarowich et al., 2018; Nanayakkara and McNamara, 2021).
Diagnostic criteria of SUD are stronger correlates of IPV than consumption patterns alone (Cafferky et al., 2018). IPV-EW are more likely than non IPV-EW to transition from misuse to SUD and have greater SUD symptom severity (Liebschutz et al., 2002; La Flair et al., 2012; Hobkirk et al., 2015). Estimates of 24%–75% (Paone et al., 1992; El-Bassel et al., 2000; Beijer et al., 2018) of women report lifetime IPV exposure at SUD treatment intake. Similarly, the prevalence of SUD in IPV-EW is greater than in the general population (Schneider et al., 2009; Smith et al., 2012; Stone and Rothman, 2019). In one study, half of women presenting to a shelter after IPV exposure report recent alcohol use, almost all of whom met criteria for alcohol use disorder (AUD; Poole et al., 2008). An overrepresentation of IPV-EW in substance use treatment facilities, and vice versa, is one indication that an optimal time to intervene for both IPV and SUD may be when women seek help for either IPV or SUD (Bennett and O’Brien, 2007; Macy and Goodbourn, 2012).
Treatment-seeking samples, however, are not always representative of the population. Self-selection occurs as treatment-seekers are limited to those who are willing and able to attain medical help. Large scale community-based studies may therefore better describe rates of SUD and IPV in the general population. Although the prevalence of co-occurring SUD and IPV are lower in the community than treatment seeking samples, the associative patterns between the two remain strong (Afifi et al., 2009, 2012). Even when controlling for a number of sociodemographic variables and psychiatric comorbidities, women in community samples who report exposure to IPV have a greater occurrence of substance misuse and SUD than those without IPV exposure (Afifi et al., 2012; La Flair et al., 2012; Salom et al., 2015). Interestingly, though, the SUD and IPV associations are often substance-specific and vary by the type of violence exposure, as will be explained in the following sections.
2.1. The IPV-SUD temporal relationship
The temporal relationship between IPV and SUD can be difficult to parse as IPV exposure and substance use often occur concurrently (Caetano et al., 2000; Nowotny and Graves, 2013; Simonelli et al., 2014), and retrospective substance use can be difficult to confirm. Most findings describe either cross-sectional or single-time point data, as opposed to time-dependent relationships (Testa and Leonard, 2001; Weinsheimer et al., 2005; Hanson, 2010; Smith et al., 2012; Hink et al., 2015; Ullman and Sigurvinsdottir, 2015; Hohman et al., 2017), although a handful of longitudinal and metanalytic studies have suggested that IPV more often precedes the onset of substance misuse/SUD (Kilpatrick et al., 1997; Testa et al., 2003; El-Bassel et al., 2005; Carbone-López et al., 2006; Devries et al., 2014; Øverup et al., 2015). While some research indicates that current misuse of alcohol (Devries et al., 2014) and other drugs (Kilpatrick et al., 1997; Moore et al., 2008) is associated with future IPV, the current review will focus on substance use patterns that emerge after experiencing IPV (El-Bassel et al., 2005).
2.2. Types and patterns of substance use following IPV
Alcohol is arguably the most commonly used psychoactive substance among IPV-EW (El-Bassel et al., 2003; Finney, 2004; Afifi et al., 2012; Kraanen et al., 2014), unsurprising as it is also the most commonly used psychoactive substance in the world (Peacock et al., 2018). Alcohol has acute analgesic properties (Neddenriep et al., 2019; Boissoneault et al., 2020), making it a particularly frequent target of misuse among individuals experiencing physical pain. In-lab alcohol administration paradigms have shown a dose–response relationship between increased blood alcohol content (BAC) and decreased pain intensity, but only once BAC surpasses the legal limit (0.08%; Thompson et al., 2017). This suggests that the use of alcohol as an analgesic requires repeated high doses, a pattern of use that increases the odds of developing AUD (Patrick et al., 2021). Testa et al. (2003) and Øverup et al. (2015) both found a high incidence of heavy/problem drinking episodes in the 1–2 year period following IPV exposure in IPV-EW relative to individuals who did not report exposure to IPV. This was supported by a 2014 meta-analysis that reported a positive association between IPV exposure and subsequent alcohol use in IPV-EW (Devries et al., 2014) although the authors emphasized the need for more multi-wave longitudinal projects due to heterogeneity of measurement and the lack of control for confounds including partner’s alcohol consumption. These studies point to the importance of considering alcohol misuse in the context of pain self-management, particularly in women who may be less likely or able to seek medical treatment for injuries sustained as the result of an IPV-related assault. Reframing alcohol use through this lens may help clinical treatment providers to restructure alcohol-related conversations to reduce stigma and shame.
Among IPV-EW who are able and seek medical care, opiates are prescribed at a staggering rate - up to four times higher than in the general population (Stene et al., 2012; Stone and Rothman, 2019). Although prescription medication use can serve to manage physical pain due to physical abuse (Poole et al., 2008; Cole and Logan, 2010; Hemsing et al., 2016; Stone and Rothman, 2019; Williams et al., 2020), there is a lack of support for long term opiate management of pain, as chronic opiate use decreases pain tolerance (Compton, 1994; Younger et al., 2008) and increases risk of physical dependence (Compton et al., 2003; Raith and Hochhaus, 2004). Further, a prospective medical chart review found that women reporting IPV exposure had higher prescription rates than the general population for opiates and benzodiazepines (Stene et al., 2012), both of which have high addiction potential and can be very dangerous when taken together (Gudin et al., 2013; Afzal and Kiyatkin, 2019). Over-prescription also can drive a transition from prescription opiate to illicit opiate use, like heroin, among treatment-seeking individuals in the general population (Hoffman et al., 2017; Volkow et al., 2019) and non-prescription opiate use has been documented among some IPV-EW (Stone and Rothman, 2019; Williams et al., 2020) and as a consequence of IPV exposure (El-Bassel et al., 2005).
Consistent with alcohol and opiate use patterns, cannabis use disorder is also more prevalent among IPV-EW than in the general population (El-Bassel et al., 2000; Gilbert et al., 2012; Smith et al., 2012). While cannabis has been touted as effective for pain management (Russo et al., 2007; Hill et al., 2017), clinical evidence remains limited, and some argue that cannabis use is more commonly used to cope with psychological as opposed to physical trauma in people exposed to IPV (El-Bassel et al., 2011; Reingle et al., 2012) and a general population of young adults (Bonn-Miller et al., 2008). Cannabis use for stress/coping purposes can increase risk of developing SUD (Hyman and Sinha, 2009) and may be accompanied by a perpetuation of depressive and anxiety disorders and suicidal ideation in adolescents (Copeland et al., 2013). Given the risk for mental health symptoms, such as depression and PTSD, among IPV-EW, and the prevalence of cannabis use in this population, research is needed to explore how cannabis interacts to either exacerbate or ameliorate mental health symptoms (Haney and Evins, 2016; Lowe et al., 2019). Moreover, cannabis use should be considered in context of polysubstance use patterns that can arise from mixing recreational and prescription psychoactive substances. Such multi-drug patterns can exacerbate unsafe and unhealthy behavioral repertoires that can increase risk for revictimization and worsening overall physical and mental health. Thus, although national approval of medicinal and recreational cannabis use is growing, the risk for misuse and dependence in IPV-EW should not be ignored.
IPV-EW have indicated that their substance use can serve as a coping mechanism for the physical, as well as emotional pain of trauma exposure (Øverup et al., 2015; Gezinski et al., 2021). Alcohol and recreational substance use in women is also impacted by partner behavior (Owens et al., 2013; Derrick et al., 2019). In IPV-EW, some perpetrators may coerce or force IPV survivors to use addictive substances (Warsaw and Tinnon, 2018). Added to that is the increased accessibility to addictive prescription medications due to the high likelihood for emergency room visits in this population because of injuries experienced (Kothari and Rhodes, 2006; Rhodes et al., 2011; Hemsing et al., 2016). While reports suggest that a primary driver of substance use in IPV-EW is self-medication, the possibility that both IPV perpetrators and the medical community may exacerbate this behavior warrants significant consideration. Substance users remain highly stigmatized in our society and clinical treatment providers are urged to account for these external factors in the complex needs of IPV-EW.
3. Factors affecting the relationship between IPV exposure and substance use
3.1. Sociodemographics
Age, education, race, and socioeconomic status are established factors in the risk for IPV exposure (Smith et al., 2018). Racial and ethnic minorities experience disproportionate rates of rape, physical violence, or stalking by an intimate partner (CDC, 2017), and over 80% of Indigenous women in the United States have experienced IPV, stalking, or sexual violence (National Institute of Justice, 2016; Rosay, 2016). Racial discrimination produces increased risk for IPV exposure (Cho et al., 2014) and developing mental health issues after violence exposure (Voth Schrag, 2017). Individuals with disabilities also experience higher rates of IPV (Hughes et al., 2011; Plummer and Findley, 2012; García-Cuéllar et al., 2022) and face additional barriers to help-seeking (Plummer and Findley, 2012). Similarly, racial discrimination increases the risk for developing a SUD (Yoo et al., 2010; Otiniano Verissimo et al., 2014; Pro et al., 2018; Matsuzaka and Knapp, 2020), and racial and ethnic minority groups experience more severe consequences related to SUDs including treatment disparities, criminal justice involvement, morbidity, mortality, and violence (Boyd et al., 2003; Smedley et al., 2003; Iguchi et al., 2005; Amaro et al., 2006; Mennis and Stahler, 2016; Matsuzaka and Knapp, 2020). Moreover, structural bias in the media has promulgated stereotypes about SUDs as a personal deficit specific to people of color, which again influences access to, and the quality of SUD treatment provided to minority groups (Matsuzaka and Knapp, 2020).
Poverty and poor economic conditions are both a risk for and consequence of IPV exposure (CDC, 2019; Fernandes-Alcantara, 2019). Socioeconomic mobility can be restricted through physical and psychological trauma by preventing educational attainment and causing job instability; 64% of IPV-EW report that violence exposure hindered their ability to work (McLean and Bocinski, 2017). Likewise, income inequalities can be perpetuated through substance use related stigma in discriminatory employment and housing practices (Earnshaw, 2020). Gender inequality in education, employment, and income further adds to this burden (Niolon et al., 2017), as does overcrowding, high unemployment rates, neighborhood disadvantage, and low social resource capital (Niolon et al., 2017; CDC, 2019). Moreover, because IPV exposure results in various physical and mental health needs, health care utilization costs are often high and many victims pay for services out of pocket or incur medical debt (McLean and Bocinski, 2017). Economic barriers also negatively impact access to quality SUD treatment (Matsuzaka and Knapp, 2020; CDC, 2022) and often delay treatment seeking due to lack of health insurance and/or reliable transportation (Schmidt et al., 2007; Matsuzaka and Knapp, 2020; CDC, 2022). This delay in treatment seeking can impact the severity of substance misuse issues and the progression to SUD (Lewis et al., 2018; Matsuzaka and Knapp, 2020). Finally, it is noteworthy that adverse childhood experiences (ACEs) including childhood physical and sexual abuse, adversity, and a family history of (or witness to) IPV are associated with increased risk for IPV exposure in adulthood as well as increased risk for substance use (LeTendre and Reed, 2017; CDC, 2018; Currie and Tough, 2021; Leza et al., 2021). For frontline care providers, it is important to consider the intersecting effects of sociodemographics on IPV and substance use risk, particularly as such factors affect the breadth and quality of treatment strategies that are accessible to certain populations. These considerations can inform decisions regarding wraparound care and connection to resources.
3.2. Mental health
Exposure to IPV is associated with increased risk for onset of mental health disorders, with incidence rates highest for depression, anxiety, PTSD, and mood disorders (Okuda et al., 2011; Ahmadabadi et al., 2020; Chandan et al., 2020; Mazza et al., 2021). Likewise, SUD demonstrates high comorbidity with mental health conditions and psychiatric disorders (Grant et al., 2015, 2016). Moreover a diagnosis of depression has been associated with subsequent alcohol misuse in IPV-EW (La Flair et al., 2012). Additionally, in IPV-EW recruited from shelter populations and community samples, 60%–90% meet diagnostic criteria for PTSD (Golding, 1999; Dutton et al., 2005, 2006; Woods et al., 2008; Nathanson et al., 2012), and show greater symptom severity than trauma-exposed women who have not experienced IPV (Pico-Alfonso, 2005; Sullivan and Holt, 2008; Woods et al., 2008). In parallel, nearly half of women who develop PTSD following exposure to IPV also develop comorbid SUD (Najavits et al., 2004; Sullivan and Holt, 2008; Sullivan et al., 2012; Najavits and Hien, 2013). Women with a history of physical IPV and comorbid PTSD were nearly 15 times more likely to have days in which they use both alcohol and drugs than IPV-EW without PTSD (Sullivan et al., 2016; McKee and Hilton, 2019). Not surprisingly, the use of alcohol and other drugs to cope with the mental health symptoms following IPV exposure can exacerbate mental health disorders, increase symptom severity, and perpetuate maladaptive coping (Poole et al., 2008; Sullivan et al., 2012; Ullman and Sigurvinsdottir, 2015; Stoicescu et al., 2019). This sets a potentially cyclical relationship between IPV exposure, substance misuse, and mental health problems, which must be considered in all clinical contexts to reduce the potential for worsening mental health outcomes and the risk for revictimization (Gearon and Bellack, 1999; Tol et al., 2019).
3.3. Brain injury and substance use
To-date, IPV-related brain injuries have been vastly understudied, yet the rates of partner-inflicted head trauma and probable brain injury among IPV-EW are estimated to be extremely high. For example, studies suggest that anywhere from 30% to 92% of participants report at least one episode of abuse with either exposure to head or neck trauma and/or probable brain injury (Jackson et al., 2002; Valera and Berenbaum, 2003; St Ivany and Schminkey, 2016; Valera and Kucyi, 2017; Esopenko et al., 2021; Campbell et al., 2022). Another recent scoping review found that the prevalence of head trauma is between 19% and 100% across studies, with the large range being due to varied definitions of head trauma and brain injury as well as varied participant inclusion characteristics (e.g., inclusion of only participants with injuries to the head; Haag et al., 2022).
Repetitive exposure to head trauma is also of significant concern as at least 50% of individuals within these samples report multiple episodes of head, neck, and facial trauma (Wilbur et al., 2001; St Ivany and Schminkey, 2016; Valera and Kucyi, 2017; Zieman et al., 2017). Imporantly, each head, neck, and/or facial trauma that occurs as a result of physical and sexual violence in IPV has the potential to result in a brain injury (Capizzi et al., 2020; Esopenko et al., 2021; Meyer et al., 2021; Saleem et al., 2021). IPV-related TBI can occur due to being punched, kicked, thrown, hit with an object, or shaken, all of which can result in focal and/or diffuse axonal injury (Sheridan and Nash, 2007; Valera et al., 2019). NFS, suffocation, and other forms of impeded breathing occurring as a result of IPV can cause hypoxic–ischemic brain injuries from a lack of, or decrease in, oxygen to the brain (Jackson et al., 2002; Valera and Berenbaum, 2003; Kwako et al., 2011; Haag et al., 2022; Valera et al., 2022). With so many avenues for brain trauma, it is probably unsurprising that estimates suggest that approximately 23 million people are living with IPV-related brain injury in the United States alone (St Ivany and Schminkey, 2016).
In the general population, there is some evidence that substance use increases following brain injury, but other factors, such as premorbid substance use, injury severity, and age at time of injury also affect this relationship (Ponsford et al., 2007; Pagulayan et al., 2016; Kennedy et al., 2017; Merkel et al., 2017; Shiwalkar et al., 2017; Schindler et al., 2021). Moreover, the high prevalence of IPV-related head trauma and probable brain injuries, coupled with other factors discussed above (e.g., comorbid mental health symptoms), likely increases the risk of SUD (Oliverio et al., 2020; Oakley et al., 2021). For example, one study of female veterans who all screened positive for TBI found that only the women who also reported a lifetime history of IPV had a SUD diagnosis (Iverson et al., 2020). In the general population, the neural changes and resulting cognitive and psychological impairments occurring after TBI are strong predictors of substance use, misuse, and development of SUD (Graham and Cardon, 2008; Weil et al., 2016; Beaulieu-Bonneau et al., 2018; Olsen and Corrigan, 2021), and contribute to poorer treatment outcomes (Corrigan and Deutschle, 2008; Graham and Cardon, 2008). However, the cause-and-effect relationship between TBI and substance use is complex and hard to parse as substance use is both a risk factor for, and sequelae of, TBI (Nikoo et al., 2017; Eskander et al., 2020). Nonetheless, there is evidence that brain injury often remains undiagnosed among IPV-EW, as substance misuse and mental health issues mask brain injury symptoms, thereby precluding effective assessment and treatment for brain injury (Banks, 2007; Haag et al., 2022). Undiagnosed brain injury has far-reaching mental and physical health consequences, and failure to identify brain injury in the clinical context could prove detrimental to the long-term outcomes of IPV-EW, by impeding delivery of adequate and effective therapies. (Comper et al., 2005). It also can perpetuate stigmas associated with SUD, such as patients being “difficult” and the disease as being intractable.
4. Facilitating substance use intervention strategies for IPV-EW
4.1. Acknowledging barriers to care
The combined exposure to IPV and SUD creates barriers (i.e., women with SUDs being denied shelter admission) that inhibit access to treatment for either IPV or SUD (Logan and Walker, 2004; Humphreys et al., 2005; Klostermann, 2006; Macy and Goodbourn, 2012). Standard trauma-informed frameworks are not always sufficient to treat the complex needs of IPV survivors who are also coping with substance use problems (Macy and Goodbourn, 2012; Capezza et al., 2015), and SUD treatment facilities rarely screen for IPV exposure (Bennett and Lawson, 1994; Collins et al., 1997; Logan et al., 2002). Another consideration is encouragement or coercion by partners to continue drug use (Gilbert et al., 2001; Simonelli et al., 2014; USDHHS, 2020). For instance, partner opposition to SUD treatment entry poses a barrier to recovery (Amaro and Hardy-Fanta, 1995; USDHHS, 2020), and IPV perpetrators may keep substances around the home and pressure or force their partner to use substances (USDHHS, 2020). Additionally, brain injury-related cognitive and neurobehavioral impairments can make it harder for those with brain injury and IPV exposure to gain access to, stick with, and benefit from standard treatments for SUD (Vungkhanching et al., 2007; Olson-Madden et al., 2012). These barriers , in general SUD samples, have been shown to undermine the likelihood of SUD treatment success (Bates et al., 2006, 2013). Thus, the creation and implementation of treatment options that include cognitive and neurobehavioral support remain urgently needed.
4.2. Screening
Given that mental health diagnoses, including SUD, increase the risk of continued and future victimization (Gearon and Bellack, 1999; Friedman and Loue, 2007), it would be beneficial for all emergency departments and mental health facilities to screen for history of IPV, and associated comorbidities, particularly exposure to head, neck, and facial trauma and probable brain injury, in anyone seeking treatment for these conditions (Waalen et al., 2000; Clark et al., 2008; Rabin et al., 2009; Radcliffe and Gilchrist, 2016; Gilchrist and Hegarty, 2017; Iverson et al., 2020). Likewise, screening for IPV and brain injury in substance use treatment programs is also needed as efficacy is significantly reduced in IPV-EW who are not receiving care and resources related to violence exposure (Capezza et al., 2015). Similarly, screening for SUD in anyone seeking IPV treatment and shelter services not only increases the safety of IPV populations, as research shows SUD is linked with re-victimization, but will also provide timely SUD treatment (Kilpatrick et al., 1997; Capaldi et al., 2012; Simmons et al., 2014, 2017; McKee and Hilton, 2019). Free, validated self-report tools, such as the Alcohol Use Disorders Identification Test (AUDIT; Saunders et al., 1993), the Drug Abuse Screening Test (DAST-10; Skinner, 1982; Bohn et al., 1991), and the Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST; Humeniuk et al., 2010) are readily available and can be used to quickly assess alcohol and substance misuse. Health care agencies could also serve a greater number of IPV-EW who need SUD treatment, but who may lack health insurance coverage and/or are financially dependent on an IPV perpetrator (Clark et al., 2008; Foster et al., 2010; Priester et al., 2016), by including an assessment of financial need to ensure access to services regardless of financial limitations (Hageman and George, 2018). Screening processes may best be facilitated by social work staff trained in resource facilitation and could increase the likelihood that basic needs are also met (Macy et al., 2013). Lastly, key stakeholders, including domestic violence and SUD agencies could further improve outcomes by screening and referring IPV-EW for brain injury-related services, as cognitive deficits resulting from brain injury can make a survivor’s physical and emotional healing more difficult (Iverson and Pogoda, 2015; Haag et al., 2022) and, more generally, SUD treatment less efficacious.
4.3. CBT-based interventions
Intervention research shows support for cognitive-behavioral therapies (CBT) as most effective for targeting PTSD, depression, emotional well-being, and substance misuse in IPV groups (Eckhardt et al., 2013; Arroyo et al., 2017). A systematic review and meta-analysis found that CBT-based interventions specifically tailored for the unique needs of IPV survivors resulted in the largest effect sizes for outcomes such as PTSD, depression, and self-esteem with moderate effect size decreases in substance use outcomes (Arroyo et al., 2017). Other recent research demonstrates the efficacy of CBT with interventions such as Helping to Overcome PTSD through Empowerment [HOPE] (Johnson and Zlotnick, 2009). This CBT-based HOPE intervention was developed specifically for IPV-EW who were also residing in a shelter and was shown to reduce the likelihood for revictimization. Cognitive Trauma Therapy for Battered Women (CTT-BW) is another intervention developed to address trauma history, exposure to abuse and abuser reminders, as well as monitoring of negative self-talk and cognitive therapy for guilt (Kubany et al., 2004). CTT-BW showed significant reductions in PTSD and depressive symptoms among IPV-EW that were maintained at 6-month follow-up (Kubany et al., 2004).
4.4. Concurrent IPV/SUD treatment
There is evidence that concurrent IPV services and substance use treatment may be a more effective approach than treating IPV or SUD on their own (Capezza and Najavits, 2012; Macy and Goodbourn, 2012; Capezza et al., 2015). For example, one treatment strategy designed to address both trauma symptoms and SUD, known as Seeking Safety, has been efficacious in reducing SUD and PTSD symptoms (Najavits, 2007) and has been recommended for use with IPV groups (Cohen et al., 2013; McKee and Hilton, 2019). By utilizing one facility with the same team of treatment personnel, coordination is efficient, cost-effective, and there is a greater likelihood that individuals will attend, complete, and benefit from the program (Mueser et al., 2003; Poole et al., 2008; Murphy and Ting, 2010; Capezza et al., 2015; McKee and Hilton, 2019).
4.5. Teaching and strengthening resilience
A crucial consideration for substance use treatment programs for IPV-EW is resilience, a process of positive adaptation despite adverse conditions (Crann and Barata, 2016; Tsirigotis and Łuczak, 2018; Rollero and Speranza, 2020; Gonzalez-Mendez and Hamby, 2021). Resilience is a skill set that promotes beneficial responses to avoid negative outcomes and reduce harmful effects on physical and psychological functioning (Luthar et al., 2000; Humphreys, 2003; Gonzalez-Mendez and Hamby, 2021). Among IPV-EW, higher resilience has been consistently correlated with lower levels of PTSD, depression, anxiety, psychological distress, and risk for substance use (Humphreys, 2003; Anderson et al., 2012; Gonçalves and Matos, 2020). Interventions that can both teach and strengthen resilience have been shown to improve IPV-EW’s confidence, independence, power, and positive social relationships, all of which contribute positive outcomes (Humphreys, 2003; Decker et al., 2020). Research has shown that IPV-EW who employ strategies such as physical activity, creativity, spirituality, introspection, and optimism are more likely to demonstrate greater resilience, positive adaptation, self-efficacy, and healing from abuse (Drumm et al., 2014; López-Fuentes and Calvete, 2015). Similarly, interventions that empower IPV-EW to access and use their strengths (e.g., social resources, help-seeking behaviors, assertiveness, problem-solving skills) enable survivors to respond to partner violence and related sequelae with healthier behavioral strategies, ultimately resulting in a decreased risk for substance use problems (Luthar et al., 2000; Humphreys, 2003; Sani and Pereira, 2020).
Several studies have documented that an increase in resilience is associated with decreased substance use and SUD recovery (Elm et al., 2016; McKinley and Theall, 2021; Yamashita et al., 2021). In fact, one study demonstrated that women with greater resilience, defined as a strong sense of self, an awareness of the abuse, a knowledge of resources, and a future hope, showed more awareness of how their abuser’s and their own substance use contributed to the maintenance of the abusive relationship (Werner-Wilson et al., 2000). This increased awareness is a crucial factor needed for ending the potentially cyclical nature of substance use in IPV (Gutierres and Van Puymbroeck, 2006). In addition, increased resilience is associated with healthier and safer decision making in IPV-EW which supports efforts to reduce risk for revictimization (McFarlane et al., 1997; Humphreys, 2003; Decker et al., 2020; Schaefer et al., 2021). The ability of resilience to reduce physical and psychological distress, while improving overall health, could make it a key target for recovery from SUD (Gorvine et al., 2021). Teaching and strengthening resilience could provide a positive, empowering, and healthy alternative for IPV-EW to obtain relief from the physical pain and psychological trauma symptoms that may be underlying the use of alcohol and other drugs (Hernandez and Mendoza, 2011; Gorvine et al., 2021). With prior research demonstrating the power of resilience to reduce substance use and misuse, future research is necessary to expand the potential for SUD prevention in IPV using the resilience framework (Gorvine et al., 2021; Yamashita et al., 2021).
5. Conclusion
The complex and cyclical relationship between IPV exposure and substance misuse warrants significantly more research and clinical attention, particularly considering that both demonstrate complex interactions with with highly comorbid factors, such as mental health problems and brain injury. Critical next steps include cross-fertilization of ideas, theories, and data from fields such as social work, psychology, neuroscience, addiction, and women’s health. This review presents evidence for an elevated risk for misuse of recreational and prescription substances in this population, but emphasizes a need for clinicians to reframe perspectives on this use to improve outcomes for all IPV-EW. Clinicians are urged to consider substance use in light of physical and emotional pain that often results from violence exposure, and take care to screen for SUDs prior to prescribing potentially addictive medications. Mental health disorders and IPV-related brain injuries are additional factors for clinicians to consider. It is only when substance use, mental health, and brain health are considered together that IPV-EW will gain access to optimal treatment strategies. In the absence of such comprehensive screening, IPV-EW may appear unable or unwilling to affect meaningful change to improve their quality of life, thereby perpetuating the stigma and bias that remains deeply entrenched against IPV survivors and substance users.
The suggested clinical approach, derived from the evidence reviewed, is for concurrent treatment of IPV and SUD, with added infrastructure for mental health and cognitive support to facilitate treatment seeking, treatment gains, and long-term quality of life - both in terms of violence exposure and substance use. Clinicians treating those with IPV should consider SUD, mental health diagnoses, and cognitive impairments in terms of clinical presentation and severity. Likewise, those providing SUD treatment should assess for IPV exposure as well as mental and brain health, as this may strongly alter the optimal treatment path (WHO, 2013). It is acknowledged, however, that such comprehensive screenings are time and resource intensive, and may not be feasible in all contexts. Yet, even for those with limited time and resources, such as emergency department health care providers and shelter workers, building knowledge of these comorbidities is essential for improving outcomes for IPV-EW. Future research should be directed at probing the interplay of SUD, brain injury, mental health, and IPV, as well as testing which screening and recovery protocols provide the best treatment outcomes in IPV-EW experiencing SUD across different contexts.
Funding
CE, EW, and DT are supported by the National Institutes of Neurological Disorders and Stroke [R01NS115957]. DT is also supported by the and the National Institute of Neurological Disorders and Stroke [R01NS122184; R61NS120249]. JB is supported by a NIH/NIAAA K-award [K02AA025123]. JP is supported through the NIH postdoctoral fellowship training program [T32AA028254]. KD-O’C is supported by the National Institute on Disability, Independent Living, and Rehabilitation [90DPTB0009] and the International Alzheimer’s and Related Dementias Research Portfolio [1RF1NS115268].
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
CE, JB, EW, DT, AM, and KD-O’C were involved in manuscript conceptualization. JM, EB, CE, and JB wrote the initial paper draft. JP and NS provided editorial and conceptual feedback. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Footnotes
1.^Brain injury will be used as an umbrella term for IPV-related TBI and/or hypoxic–ischemic brain injury (described in section 3.3).
References
1
AfifiT. O.HenriksenC. A.AsmundsonG. J. G.SareenJ. (2012). Victimization and perpetration of intimate partner violence and substance use disorders in a nationally representative sample. J. Nerv. Ment. Dis.200, 684–691. doi: 10.1097/NMD.0b013e3182613f64
2
AfifiT. O.MacMillanH.CoxB. J.AsmundsonG. J. G.SteinM. B.SareenJ. (2009). Mental health correlates of intimate partner violence in marital relationships in a nationally representative sample of males and females. J. Interpers. Violence24, 1398–1417. doi: 10.1177/0886260508322192
3
AfzalA.KiyatkinE. A. (2019). Interactions of benzodiazepines with heroin: respiratory depression, temperature effects, and behavior. Neuropharmacology158:107677. doi: 10.1016/j.neuropharm.2019.107677
4
AhmadabadiZ.NajmanJ. M.WilliamsG. M.ClavarinoA. M.d’AbbsP.TranN. (2020). Intimate partner violence and subsequent depression and anxiety disorders. Soc. Psychiatry Psychiatr. Epidemiol.55, 611–620. doi: 10.1007/s00127-019-01828-1
5
AlfordD. P.GermanJ. S.SametJ. H.ChengD. M.Lloyd-TravagliniC. A.SaitzR. (2016). Primary care patients with drug use report chronic pain and Self-medicate with alcohol and other drugs. J. Gen. Intern. Med.31, 486–491. doi: 10.1007/s11606-016-3586-5
6
AlhusenJ. L.FrohmanN.PurcellG. (2015). Intimate partner violence and suicidal ideation in pregnant women. Arch. Womens Ment. Health18, 573–578. doi: 10.1007/s00737-015-0515-2
7
AmaroH.ArévaloS.GonzalezG.SzapocznikJ.IguchiM. Y. (2006). Needs and scientific opportunities for research on substance abuse treatment among Hispanic adults. Drug Alcohol Depend.84, S64–S75. doi: 10.1016/j.drugalcdep.2006.05.008
8
AmaroH.Hardy-FantaC. (1995). Gender relations in addiction and recovery. J. Psychoactive Drugs27, 325–337. doi: 10.1080/02791072.1995.10471698
9
AndersonK. M.RennerL. M.DanisF. S. (2012). Recovery: resilience and growth in the aftermath of domestic violence. Violence Against Women18, 1279–1299. doi: 10.1177/1077801212470543
10
ArroyoK.LundahlB.ButtersR.VanderlooM.WoodD. S. (2017). Short-term interventions for survivors of intimate partner violence: a systematic review and meta-analysis. Trauma Violence Abuse18, 155–171. doi: 10.1177/1524838015602736
11
BaltarowichL.MillerJ.HurstG.VarmaA.Gardner-GrayJ.PflaumJ.et al. (2018). The changing face of acute liver failure in the wake of the us prescription opioid epidemic: review of 327 cases of acetaminophen-induced acute liver failure over 12 years. Clin. Toxicol.56, 913–914.
12
BanksM. E. (2007). Overlooked but critical: traumatic brain injury as a consequence of interpersonal violence. Trauma Violence Abuse8, 290–298. doi: 10.1177/1524838007303503
13
BatesM. E.PawlakA. P.ToniganJ. S.BuckmanJ. F. (2006). Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change. Psychol. Addict. Behav.20, 241–253. doi: 10.1037/0893-164X.20.3.241
14
BatesM. E.BuckmanJ. F.NguyenT. T. (2013). A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. Neuropsychol. Rev.23, 27–47. doi: 10.1007/s11065-013-9228-3
15
Beaulieu-BonneauS.St-OngeF.BlackburnM.-C.BanvilleA.Paradis-GirouxA.-A.OuelletM.-C. (2018). Alcohol and drug use before and during the first year after traumatic brain injury. J. Head Trauma Rehabil.33, E51–E60. doi: 10.1097/HTR.0000000000000341
16
BeijerU.Scheffel BirathC.DeMartinisV.Af KlintebergB. (2018). Facets of male violence against women with substance abuse problems: women with a residence and homeless women. J. Interpers. Violence33, 1391–1411. doi: 10.1177/0886260515618211
17
BennettL.LawsonM. (1994). Barriers to cooperation between domestic-violence and substance-abuse programs. Fam. Soc.75, 277–286. doi: 10.1177/104438949407500503
18
BennettL.O’BrienP. (2007). Effects of coordinated Services for Drug-Abusing Women who are Victims of intimate partner violence. Violence Against Women13, 395–411. doi: 10.1177/1077801207299189
19
BohnM. J.BaborT. F.KranzlerH. R. (1991). “Validity of the drug abuse screening test (DAST-10) in inpatient substance abusers” in Problems of Drug Dependence. ed. L. Harris (Bethesda, MD: Department of Health, education, and welfare, public health service, alcohol, drug abuse, and mental health administration, National Institute on Drug Abuse, Division of Research)
20
BoissoneaultJ.StennettB.RobinsonM. E. (2020). Acute alcohol intake alters resting state functional connectivity of nucleus accumbens with pain-related corticolimbic structures. Drug Alcohol Depend.207:107811. doi: 10.1016/j.drugalcdep.2019.107811
21
Bonn-MillerM. O.VujanovicA. A.ZvolenskyM. J. (2008). Emotional Dysregulation: association with coping-oriented marijuana use motives among current marijuana users. Subst. Use Misuse43, 1653–1665. doi: 10.1080/10826080802241292
22
BoydM. R.PhillipsK.DorseyC. J. (2003). Alcohol and other drug disorders, comorbidity, and violence: comparison of rural African American and Caucasian women. Arch. Psychiatr. Nurs.17, 249–258. doi: 10.1053/j.apnu.2003.10.003
23
BraitsteinP.LiK.TyndallM.SpittalP.O’ShaughnessyM. V.SchilderA.et al. (2003). Sexual violence among a cohort of injection drug users. Soc. Sci. Med.57, 561–569. doi: 10.1016/S0277-9536(02)00403-3
24
BreidingM. J.ChenJ.BlackM. C. (2014). Intimate Partner Violence in the United States – 2010. Atlanta, GA: National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.
25
BrignoneE.SorrentinoA. E.RobertsC. B.DichterM. E. (2018). Suicidal ideation and behaviors among women veterans with recent exposure to intimate partner violence. Gen. Hosp. Psychiatry55, 60–64. doi: 10.1016/j.genhosppsych.2018.10.006
26
CaetanoR.CunradiC. B.SchaferJ.ClarkC. L. (2000). Intimate partner violence and drinking patterns among white, Black, and Hispanic couples in the U.S. J. Subst. Abus.11, 123–138. doi: 10.1016/S0899-3289(00)00015-8
27
CafferkyB. M.MendezM.AndersonJ. R.StithS. M. (2018). Substance use and intimate partner violence: a meta-analytic review. Psychol. Violence8, 110–131. doi: 10.1037/vio0000074
28
CampbellJ. C. (2002). Health consequences of intimate partner violence. Lancet359, 1331–1336. doi: 10.1016/S0140-6736(02)08336-8
29
CampbellJ. K.JosephA.-L. C.RothmanE. F.ValeraE. M. (2022). The prevalence of brain injury among survivors and perpetrators of intimate partner violence and the prevalence of violence victimization and perpetration among people with brain injury: a scoping review. Curr. Epidemiol. Rep.9, 290–315. doi: 10.1007/s40471-022-00302-y
30
CapaldiD. M.KnobleN. B.ShorttJ. W.KimH. K. (2012). A systematic review of risk factors for intimate partner violence. Partn. Abus.3, 231–280. doi: 10.1891/1946-6560.3.2.231
31
CapezzaN. M.NajavitsL. M. (2012). Rates of trauma-informed counseling at substance abuse treatment facilities: reports from over 10, 000 programs. Psychiatr. Serv.63, 390–394. doi: 10.1176/appi.ps.201000560
32
CapezzaN. M.SchumacherE. C.BradyB. C. (2015). Trends in intimate partner violence services provided by substance abuse treatment facilities: findings from a National Sample. J. Fam. Viol.30, 85–91. doi: 10.1007/s10896-014-9649-7
33
CapizziA.WooJ.Verduzco-GutierrezM. (2020). Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med. Clin. North Am.104, 213–238. doi: 10.1016/j.mcna.2019.11.001
34
Carbone-LópezK.KruttschnittC.MacmillanR. (2006). Patterns of intimate partner violence and their associations with physical health, psychological distress, and substance use. Public Health Rep.121, 382–392. doi: 10.1177/003335490612100406
35
CDC (2017). National intimate partner and sexual violence survey. U.S. Department of Health & Human Services. Available at: https://www.cdc.gov/violenceprevention/pdf/NISVS-StateReportBook.pdf (Accessed December 11, 2022).
36
CDC (2018). Adverse childhood experiences resources. U.S. Department of Health & Human Services. Available at: https://www.cdc.gov/violenceprevention/aces/resources.html (Accessed July 27, 2021).
37
CDC (2019). Risk and protective factors for perpetration. U.S. Department of Health & Human Services. Available at: https://www.cdc.gov/violenceprevention/intimatepartnerviolence/riskprotectivefactors.html (Accessed December 11, 2022).
38
CDC (2022). Drug overdose deaths rise, disparities widen differences grew by race, ethnicity, and other factors. U.S. Department of Health & Human Services. Available at: https://www.cdc.gov/vitalsigns/overdose-death-disparities/index.html (Accessed December 11, 2022).
39
ChandanJ. S.ThomasT.Bradbury-JonesC.RussellR.BandyopadhyayS.NirantharakumarK.et al. (2020). Female survivors of intimate partner violence and risk of depression, anxiety and serious mental illness. Br. J. Psychiatry217, 562–567. doi: 10.1192/bjp.2019.124
40
ChoH.Velez-OrtizD.Parra-CardonaJ. R. (2014). Prevalence of intimate partner violence and associated risk factors among Latinos/as: an exploratory study with three Latino subpopulations. Violence Against Women20, 1041–1058. doi: 10.1177/1077801214549636
41
CilG.ParkJ.BergenA. W. (2019). Self-reported prescription drug use for pain and for sleep and incident frailty. J. Am. Geriatr. Soc.67, 2474–2481. doi: 10.1111/jgs.16214
42
ClarkH. W.PowerA. K.Le FauveC. E.LopezE. I. (2008). Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. J. Subst. Abus. Treat.34, 3–13. doi: 10.1016/j.jsat.2006.12.032
43
CohenL. R.FieldC.CampbellA. N. C.HienD. A. (2013). Intimate partner violence outcomes in women with PTSD and substance use: a secondary analysis of NIDA clinical trials network “women and trauma” multi-site study. Addict. Behav.38, 2325–2332. doi: 10.1016/j.addbeh.2013.03.006
44
ColeJ.LoganT. K. (2010). Nonmedical use of sedative-hypnotics and opiates among rural and urban women with protective orders. J. Addict. Dis.29, 395–409. doi: 10.1080/10550887.2010.489453
45
CollinsJ. J.KroutilL. A.RolandE. J.Moore-GurreraM. (1997). “Issues in the linkage of alcohol and domestic violence services” in Recent developments in alcoholism: Volume 13: Alcohol and violence-epidemiology neurobiology psychology family issues recent development in alcoholism. eds. GalanterM.BegleiterH.DeitrichR.FullerR.GallantD.GoodwinD.et al. (Boston, MA: Springer US), 387–405. doi: 10.1007/0-306-47141-8_20
46
ComperP.BisschopS. M.CarnideN.TriccoA. (2005). A systematic review of treatments for mild traumatic brain injury. Brain Inj.19, 863–880. doi: 10.1080/02699050400025042
47
ComptonM. A. (1994). Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. J. Pain Symptom Manag.9, 462–473. doi: 10.1016/0885-3924(94)90203-8
48
ComptonP.AthanasosP.ElashoffD. (2003). Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study. J. Pain4, 511–519. doi: 10.1016/j.jpain.2003.08.003
49
CopelandJ.RookeS.SwiftW. (2013). Changes in cannabis use among young people: impact on mental health. Curr. Opin. Psychiatry26, 325–329. doi: 10.1097/YCO.0b013e328361eae5
50
CorriganJ. D.DeutschleJ. J. (2008). The presence and impact of traumatic brain injury among clients in treatment for co-occurring mental illness and substance abuse. Brain Inj.22, 223–231. doi: 10.1080/02699050801938967
51
CrannS. E.BarataP. C. (2016). The experience of resilience for adult female survivors of intimate partner violence: a phenomenological inquiry. Violence Against Women22, 853–875. doi: 10.1177/1077801215612598
52
CunninghamR. M.MurrayR.WaltonM. A.ChermackS. T.WojnarM.WozniakP.et al. (2009). Prevalence of past year assault among inner-city emergency department patients. Ann. Emerg. Med.53, 814–823.e15. doi: 10.1016/j.annemergmed.2009.01.016
53
CurrieC. L.ToughS. C. (2021). Adverse childhood experiences are associated with illicit drug use among pregnant women with middle to high socioeconomic status: findings from the all our families cohort. BMC Pregnancy Childbirth21:133. doi: 10.1186/s12884-021-03591-1
54
DardisC. M.UllmanS. E.RodriguezL. M.WatermanE. A.DworkinE. R.EdwardsK. M. (2021). Bidirectional associations between alcohol use and intimate partner violence and sexual assault victimization among college women. Addict. Behav.116:106833. doi: 10.1016/j.addbeh.2021.106833
55
DeckerM. R.WoodS. N.HameeduddinZ.KennedyS. R.PerrinN.TallamC.et al. (2020). Safety decision-making and planning mobile app for intimate partner violence prevention and response: randomised controlled trial in Kenya. BMJ Glob. Health5:e002091. doi: 10.1136/bmjgh-2019-002091
56
DerrickJ. L.WittkowerL. D.PierceJ. D. (2019). Committed relationships and substance use: recent findings and future directions. Curr. Opin. Psychol.30, 74–79. doi: 10.1016/j.copsyc.2019.03.002
57
DevriesK. M.ChildJ. C.BacchusL. J.MakJ.FalderG.GrahamK.et al. (2014). Intimate partner violence victimization and alcohol consumption in women: a systematic review and meta-analysis. Addiction109, 379–391. doi: 10.1111/add.12393
58
DevriesK. M.MakJ. Y. T.García-MorenoC.PetzoldM.ChildJ. C.FalderG.et al. (2013). The global prevalence of intimate partner violence against women. Science340, 1527–1528. doi: 10.1126/science.1240937
59
DrummR.PopescuM.CooperL.TrecartinS.SeifertM.FosterT.et al. (2014). “God just brought me through it”: spiritual coping strategies for resilience among intimate partner violence survivors. Clin. Soc. Work. J.42, 385–394. doi: 10.1007/s10615-013-0449-y
60
DuttonM. A.GreenB. L.KaltmanS. I.RoeschD. M.ZeffiroT. A.KrauseE. D. (2006). Intimate partner violence, PTSD, and adverse health outcomes. J. Interpers. Violence21, 955–968. doi: 10.1177/0886260506289178
61
DuttonM. A.KaltmanS.GoodmanL. A.WeinfurtK.VankosN. (2005). Patterns of intimate partner violence: correlates and outcomes. Violence Vict.20, 483–497. doi: 10.1891/vivi.2005.20.5.483
62
Dwyer-LindgrenL.Bertozzi-VillaA.StubbsR. W.MorozoffC.ShirudeS.UnützerJ.et al. (2018). Trends and patterns of geographic variation in mortality from substance use disorders and intentional injuries among US counties, 1980-2014. JAMA319, 1013–1023. doi: 10.1001/jama.2018.0900
63
EarnshawV. A. (2020). Stigma and substance use disorders: a clinical, research, and advocacy agenda. Am. Psychol.75, 1300–1311. doi: 10.1037/amp0000744
64
EckhardtC. I.MurphyC. M.WhitakerD. J.SprungerJ.DykstraR.WoodardK. (2013). The effectiveness of intervention programs for perpetrators and victims of intimate partner violence. Partn. Abus.4, 196–231. doi: 10.1891/1946-6560.4.2.196
65
El-BasselN.GilbertL.SchillingR.WadaT. (2000). Drug abuse and partner violence among women in methadone treatment. J. Fam. Violence15, 209–228. doi: 10.1023/A:1007532917759
66
El-BasselN.GilbertL.WitteS.WuE.ChangM. (2011). Intimate partner violence and HIV among drug-involved women: contexts linking these two epidemics—challenges and implications for prevention and treatment. Subst. Use Misuse46, 295–306. doi: 10.3109/10826084.2011.523296
67
El-BasselN.GilbertL.WitteS.WuE.GaetaT.SchillingR.et al. (2003). Intimate partner violence and substance abuse among minority women receiving care from an inner-city emergency department. Womens Health Issues13, 16–22. doi: 10.1016/S1049-3867(02)00142-1
68
El-BasselN.GilbertL.WuE.GoH.HillJ. (2005). Relationship between drug abuse and intimate partner violence: a longitudinal study among women receiving methadone. Am. J. Public Health95, 465–470. doi: 10.2105/AJPH.2003.023200
69
ElmJ. H. L.LewisJ. P.WaltersK. L.SelfJ. M. (2016). “I’m in this world for a reason”: resilience and recovery among American Indian and Alaska native two-spirit women. J. Lesbian Stud.20, 352–371. doi: 10.1080/10894160.2016.1152813
70
EskanderN.PrabhudesaiS.ImranH.Ceren AmukO.PatelR. S. (2020). Alcohol use disorder increases risk of traumatic brain injury-related hospitalization: insights from 3.8 million children and adolescent inpatients. Cureus12:e8740. doi: 10.7759/cureus.8740
71
EsopenkoC.MeyerJ.WildeE. A.MarshallA. D.TateD. F.LinA. P.et al. (2021). A global collaboration to study intimate partner violence-related head trauma: the ENIGMA consortium IPV working group. Brain Imaging Behav.15, 475–503. doi: 10.1007/s11682-020-00417-0
72
Fernandes-AlcantaraA. L. (2019). Family violence prevention and services act (FVPSA): Background and funding. Congressional Research Service (CRS). Available at: https://crsreports.congress.gov/product/pdf/R/R42838 (Accessed December 11, 2022).
73
FinneyA. (2004). Alcohol and intimate partner violence: key findings from the research. Great Britain Home Office Research Development and Statistics Directorate Available at: https://www.ojp.gov/ncjrs/virtual-library/abstracts/alcohol-and-intimate-partner-violence-key-findings-research (Accessed June 10, 2021).
74
FletcherJ. (2010). The effects of intimate partner violence on health in young adulthood in the United States. Soc. Sci. Med.70, 130–135. doi: 10.1016/j.socscimed.2009.09.030
75
FosterS.LeFauveC.Kresky-WolffM.RickardsL. D. (2010). Services and supports for individuals with co-occurring disorders and long-term homelessness. J. Behav. Health Serv. Res.37, 239–251. doi: 10.1007/s11414-009-9190-2
76
FriedmanS. H.LoueS. (2007). Incidence and prevalence of intimate partner violence by and against women with severe mental illness. J Womens Health (Larchmt)16, 471–480. doi: 10.1089/jwh.2006.0115
77
García-CuéllarM. M.Pastor-MorenoG.Ruiz-PérezI.Henares-MontielJ. (2022). The prevalence of intimate partner violence against women with disabilities: a systematic review of the literature. Disabil. Rehabil., 1–8. doi: 10.1080/09638288.2022.2025927
78
GearonJ. S.BellackA. S. (1999). Women with schizophrenia and co-occurring substance use disorders: an increased risk for violent victimization and HIV. Community Ment. Health J.35, 401–419. doi: 10.1023/a:1018778310859
79
GezinskiL. B.Gonzalez-PonsK. M.RogersM. M. (2021). Substance use as a coping mechanism for survivors of intimate partner violence: implications for safety and service accessibility. Violence Against Women27, 108–123. doi: 10.1177/1077801219882496
80
GilbertL.El-BasselN.ChangM.WuE.RoyL. (2012). Substance use and partner violence among urban women seeking emergency care. Psychol. Addict. Behav.26, 226–235. doi: 10.1037/a0025869
81
GilbertL.El-BasselN.RajahV.FolenoA.FryeV. (2001). Linking drug-related activities with experiences of partner violence: a focus group study of women in methadone treatment. Violence Vict.16, 517–536.
82
GilchristG.HegartyK. (2017). Tailored integrated interventions for intimate partner violence and substance use are urgently needed. Drug Alcohol Rev.36, 3–6. doi: 10.1111/dar.12526
83
GjersingL.Bretteville-JensenA. L. (2018). Patterns of substance use and mortality risk in a cohort of “hard-to-reach” polysubstance users. Addiction113, 729–739. doi: 10.1111/add.14053
84
GoldingJ. M. (1999). Intimate partner violence as a risk factor for mental disorders: a meta-analysis. J. Fam. Violence14, 99–132. doi: 10.1023/A:1022079418229
85
GonçalvesM.MatosM. (2020). Mental health of multiple victimized immigrant women in Portugal: does resilience make a difference?J. Hum. Behav. Soc. Environ.30, 353–368. doi: 10.1080/10911359.2019.1685423
86
Gonzalez-MendezR.HambyS. (2021). Identifying Women’s strengths for promoting resilience after experiencing intimate partner violence. Violence Vict.36, 29–44. doi: 10.1891/VV-D-18-00178
87
GorvineM. M.HaynesT. F.MarshallS. A.ClarkC. J.LoveladyN. N.ZallerN. D. (2021). A qualitative exploration of Women’s lives and resilience in substance use disorder recovery. Integr Med (Encinitas).20, 20–29.
88
GrahamD. P.CardonA. L. (2008). An update on substance use and treatment following traumatic brain injury. Ann. N. Y. Acad. Sci.1141, 148–162. doi: 10.1196/annals.1441.029
89
GrantB. F.GoldsteinR. B.SahaT. D.ChouS. P.JungJ.ZhangH.et al. (2015). Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on alcohol and related conditions III. JAMA Psychiat.72, 757–766. doi: 10.1001/jamapsychiatry.2015.0584
90
GrantB. F.SahaT. D.RuanW. J.GoldsteinR. B.ChouS. P.JungJ.et al. (2016). Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on alcohol and related conditions-III. JAMA Psychiat.73, 39–47. doi: 10.1001/jamapsychiatry.2015.2132
91
GudinJ. A.MogaliS.JonesJ. D.ComerS. D. (2013). Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgrad. Med.125, 115–130. doi: 10.3810/pgm.2013.07.2684
92
GutierresS. E.Van PuymbroeckC. (2006). Childhood and adult violence in the lives of women who misuse substances. Aggress. Violent Behav.11, 497–513. doi: 10.1016/j.avb.2006.01.010
93
HaagH.JonesD.JosephT.ColantonioA. (2022). Battered and brain injured: traumatic brain injury among women survivors of intimate partner violence—a scoping review. Trauma Violence Abuse23, 1270–1287. doi: 10.1177/1524838019850623
94
HagemanS. A.GeorgeD. M. M. S. (2018). Social workers, intimate partner violence (IPV), and client financial concerns. J. Soc. Serv. Res.44, 391–399. doi: 10.1080/01488376.2018.1476288
95
HallM. T.GolderS.HigginsG. E.LoganT. K. (2016). Nonmedical prescription opioid use among victimized women on probation and parole. Addict. Behav.53, 113–119. doi: 10.1016/j.addbeh.2015.10.008
96
HaneyM.EvinsA. E. (2016). Does cannabis cause, exacerbate or ameliorate psychiatric disorders? An oversimplified debate discussed. Neuropsychopharmacology41, 393–401. doi: 10.1038/npp.2015.251
97
HansonM. J. (2010). Health behavior in adolescent women reporting and not reporting intimate partner violence. J Obstet Gynecol Neonatal Nurs39, 263–276. doi: 10.1111/j.1552-6909.2010.01138.x
98
HemsingN.GreavesL.PooleN.SchmidtR. (2016). Misuse of prescription opioid medication among women: a scoping review. Pain Res. Manag.2016:e1754195. doi: 10.1155/2016/1754195
99
HernandezV. R.MendozaC. T. (2011). Shame resilience: a strategy for empowering women in treatment for substance abuse. J. Soc. Work. Pract. Addict.11, 375–393. doi: 10.1080/1533256X.2011.622193
100
HillK. P.PalastroM. D.JohnsonB.DitreJ. W. (2017). Cannabis and pain: a clinical review. Cannabis Cannabinoid Res.2, 96–104. doi: 10.1089/can.2017.0017
101
HinkA. B.ToschlogE.WaibelB.BardM. (2015). Risks go beyond the violence: association between intimate partner violence, mental illness, and substance abuse among females admitted to a rural level I trauma center. J. Trauma Acute Care Surg.79, 709–716. doi: 10.1097/TA.0000000000000856
102
HobkirkA. L.WattM. H.GreenK. T.BeckhamJ. C.SkinnerD.MeadeC. S. (2015). Mediators of interpersonal violence and drug addiction severity among methamphetamine users in Cape Town, South Africa. Addict. Behav.0, 167–171. doi: 10.1016/j.addbeh.2014.11.030
103
HoffmanL. A.LewisB.NixonS. J. (2017). Opioid misuse trends in treatment seeking populations: revised prescription opioid policy and temporally corresponding changes. Subst. Use Misuse52, 1850–1858. doi: 10.1080/10826084.2017.1316291
104
HogarthL.MartinL.SeedatS. (2019). Relationship between childhood abuse and substance misuse problems is mediated by substance use coping motives, in school attending south African adolescents. Drug Alcohol Depend.194, 69–74. doi: 10.1016/j.drugalcdep.2018.10.009
105
HohmanM.BarkerM.WoodruffS. (2017). What lies beneath: trauma events, PTSD, and alcohol misuse in driving under the influence program clients. J. Soc. Work. Pract. Addict.17, 95–113. doi: 10.1080/1533256X.2017.1302885
106
HughesR. B.LundE. M.GabrielliJ.PowersL. E.CurryM. A. (2011). Prevalence of interpersonal violence against community-living adults with disabilities: a literature review. Rehabil. Psychol.56, 302–319. doi: 10.1037/a0025620
107
HumeniukR.Henry-EdwardsS.AliR.PoznyakV.MonteiroM. G. (2010). The alcohol, Smoking and Substance involvement Screening Test (ASSIST): Manual for use in primary care. Available at: https://www.cabdirect.org/cabdirect/abstract/20133034036 (Accessed December 11, 2022).
108
HumphreysJ. (2003). Resilience in sheltered battered women. Issues Ment. Health Nurs.24, 137–152. doi: 10.1080/01612840305293
109
HumphreysC.ThiaraR. K.ReaganL. (2005). Domestic Violence and Substance Use: Overlapping Issues in Separate Services?. London: Greater London Authority.
110
HymanS. M.SinhaR. (2009). Stress-related factors in cannabis use and misuse: implications for prevention and treatment. J. Subst. Abus. Treat.36, 400–413. doi: 10.1016/j.jsat.2008.08.005
111
IguchiM. Y.BellJ.RamchandR. N.FainT. (2005). How criminal system racial disparities may translate into health disparities. J. Health Care Poor Underserved16, 48–56. doi: 10.1353/hpu.2005.0114
112
Iovine-WongP. E.Nichols-HadeedC.Thompson StoneJ.GambleS.CrossW.CerulliC.et al. (2019). Intimate partner violence, suicide, and their overlapping risk in women veterans: a review of the literature. Mil. Med.184, e201–e210. doi: 10.1093/milmed/usy355
113
IversonK. M.PogodaT. K. (2015). Traumatic brain injury among women veterans: an invisible wound of intimate partner violence. Med. Care53, S112–S119. doi: 10.1097/MLR.0000000000000263
114
IversonK. M.SayerN. A.MeterkoM.StolzmannK.SuriP.GormleyK.et al. (2020). Intimate partner violence among female OEF/OIF/OND veterans who were evaluated for traumatic brain injury in the veterans health administration: a preliminary investigation. J. Interpers. Violence35, 2422–2445. doi: 10.1177/0886260517702491
115
JacksonH.PhilpE.NuttallR. L.DillerL. (2002). Traumatic brain injury: a hidden consequence for battered women. Prof. Psychol. Res. Pract.33, 39–45. doi: 10.1037/0735-7028.33.1.39
116
JohnsonD. M.ZlotnickC. (2009). HOPE for battered women with PTSD in domestic violence shelters. Prof. Psychol. Res. Pract.40, 234–241. doi: 10.1037/a0012519
117
KennedyE.HeronJ.MunafòM. (2017). Substance use, criminal behaviour and psychiatric symptoms following childhood traumatic brain injury: findings from the ALSPAC cohort. Eur. Child Adolesc. Psychiatry26, 1197–1206. doi: 10.1007/s00787-017-0975-1
118
KilpatrickD. G.AciernoR.ResnickH. S.SaundersB. E.BestC. L. (1997). A 2-year longitudinal analysis of the relationships between violent assault and substance use in women. J. Consult. Clin. Psychol.65, 834–847. doi: 10.1037//0022-006x.65.5.834
119
KingeryP. M.PruittB. E.HurleyR. S. (1992). Violence and illegal drug use among adolescents: evidence from the U.S. National Adolescent Student Health Survey. Int. J. Addict.27, 1445–1464. doi: 10.3109/10826089209047362
120
KlostermannK. C. (2006). Substance abuse and intimate partner violence: treatment considerations. Subst. Abuse Treat. Prev. Policy1:24. doi: 10.1186/1747-597X-1-24
121
KothariC. L.RhodesK. V. (2006). Missed opportunities: emergency department visits by police-identified victims of intimate partner violence. Ann. Emerg. Med.47, 190–199. doi: 10.1016/j.annemergmed.2005.10.016
122
KraanenF. L.VedelE.ScholingA.EmmelkampP. M. G. (2014). Prediction of intimate partner violence by type of substance use disorder. J. Subst. Abus. Treat.46, 532–539. doi: 10.1016/j.jsat.2013.10.010
123
KubanyE. S.HillE. E.OwensJ. A.Iannce-SpencerC.McCaigM. A.TremayneK. J.et al. (2004). Cognitive trauma therapy for battered women with PTSD (CTT-BW). J. Consult. Clin. Psychol.72, 3–18. doi: 10.1037/0022-006X.72.1.3
124
KwakoL. E.GlassN.CampbellJ.MelvinK. C.BarrT.GillJ. M. (2011). Traumatic brain injury in intimate partner violence: a critical review of outcomes and mechanisms. Trauma Violence Abuse12, 115–126. doi: 10.1177/1524838011404251
125
La FlairL. N.BradshawC. P.StorrC. L.GreenK. M.AlvanzoA. A. H.CrumR. M. (2012). Intimate partner violence and patterns of alcohol abuse and dependence criteria among women: a latent class analysis. J. Stud. Alcohol Drugs73, 351–360. doi: 10.15288/jsad.2012.73.351
126
LakeS.KennedyM. C. (2016). Health outcomes associated with illicit prescription opioid injection: a systematic review. J. Addict. Dis.35, 73–91. doi: 10.1080/10550887.2015.1127712
127
LehavotK.StappenbeckC. A.LuterekJ. A.KaysenD.SimpsonT. L. (2014). Gender differences in relationships among PTSD severity, drinking motives, and alcohol use in a comorbid alcohol dependence and PTSD sample. Psychol. Addict. Behav.28, 42–52. doi: 10.1037/a0032266
128
LeTendreM. L.ReedM. B. (2017). The effect of adverse childhood experience on clinical diagnosis of a substance use disorder: results of a nationally representative study. Subst. Use Misuse52, 689–697. doi: 10.1080/10826084.2016.1253746
129
LewisB.HoffmanL.GarciaC. C.NixonS. J. (2018). Race and socioeconomic status in substance use progression and treatment entry. J. Ethn. Subst. Abus.17, 150–166. doi: 10.1080/15332640.2017.1336959
130
LezaL.SiriaS.López-GoñiJ. J.Fernández-MontalvoJ. (2021). Adverse childhood experiences (ACEs) and substance use disorder (SUD): a scoping review. Drug Alcohol Depend.221:108563. doi: 10.1016/j.drugalcdep.2021.108563
131
LiebschutzJ.SavetskyJ. B.SaitzR.HortonN. J.Lloyd-TravagliniC.SametJ. H. (2002). The relationship between sexual and physical abuse and substance abuse consequences. J. Subst. Abus. Treat.22, 121–128. doi: 10.1016/s0740-5472(02)00220-9
132
LoganT. K.WalkerR. (2004). Separation as a risk factor for victims of intimate partner violence: beyond lethality and injury: a response to Campbell. J. Interpers. Violence19, 1478–1486. doi: 10.1177/0886260504269699
133
LoganT.WalkerR.ColeJ.LeukefeldC. (2002). Victimization and substance abuse among women: contributing factors, interventions, and implications. Rev. Gen. Psychol.6, 325–397. doi: 10.1037/1089-2680.6.4.325
134
López-FuentesI.CalveteE. (2015). Building resilience: a qualitative study of Spanish women who have suffered intimate partner violence. Am. J. Orthopsychiatry85, 339–351. doi: 10.1037/ort0000070
135
LoweD. J. E.SasiadekJ. D.ColesA. S.GeorgeT. P. (2019). Cannabis and mental illness: a review. Eur. Arch. Psychiatry Clin. Neurosci.269, 107–120. doi: 10.1007/s00406-018-0970-7
136
LutgendorfM. A. (2019). Intimate partner violence and Women’s health. Obstet. Gynecol.134, 470–480. doi: 10.1097/AOG.0000000000003326
137
LutharS. S.CicchettiD.BeckerB. (2000). The construct of resilience: a critical evaluation and guidelines for future work. Child Dev.71, 543–562. doi: 10.1111/1467-8624.00164
138
MacyR. J.GoodbournM. (2012). Promoting successful collaborations between domestic violence and substance abuse treatment service sectors: a review of the literature. Trauma Violence Abuse13, 234–251. doi: 10.1177/1524838012455874
139
MacyR. J.RenzC.PelinoE. (2013). Partner violence and substance abuse are intertwined: Women’s perceptions of violence–substance connections. Violence Against Women19, 881–902. doi: 10.1177/1077801213498208
140
MartinoS. C.CollinsR. L.EllicksonP. L. (2005). Cross-lagged relationships between substance use and intimate partner violence among a sample of young adult women. J. Stud. Alcohol66, 139–148. doi: 10.15288/jsa.2005.66.139
141
MatsuzakaS.KnappM. (2020). Anti-racism and substance use treatment: addiction does not discriminate, but do we?J. Ethn. Subst. Abus.19, 567–593. doi: 10.1080/15332640.2018.1548323
142
MazzaM.MaranoG.CastilloA. G. D.ChieffoD.MontiL.JaniriD.et al. (2021). Intimate partner violence: a loop of abuse, depression and victimization. World J. Psychiatry11, 215–221. doi: 10.5498/wjp.v11.i6.215
143
McFarlaneJ.SoekenK.ReelS.ParkerB.SilvaC. (1997). Resource use by abused women following an intervention program: associated severity of abuse and reports of abuse ending. Public Health Nurs.14, 244–250. doi: 10.1111/j.1525-1446.1997.tb00297.x
144
McKeeS. A.HiltonN. Z. (2019). Co-occurring substance use, PTSD, and IPV victimization: implications for female offender services. Trauma Violence Abuse20, 303–314. doi: 10.1177/1524838017708782
145
McKinleyC. E.TheallK. P. (2021). Weaving healthy families program: promoting resilience while reducing violence and substance use. Res. Soc. Work. Pract.31, 476–492. doi: 10.1177/1049731521998441
146
McLeanG.BocinskiS. G. (2017). The economic cost of intimate partner violence, sexual assault, and stalking. Institute for Women’s Policy Research. Available at: https://iwpr.org/wp-content/uploads/2020/10/B367_Economic-Impacts-of-IPV-08.14.17.pdf (Accessed December 11, 2022).
147
McLellanA. T. (2017). Substance misuse and substance use disorders: why do they matter in healthcare?Trans. Am. Clin. Climatol. Assoc.128, 112–130. PMID:
148
MennisJ.StahlerG. J. (2016). Racial and ethnic disparities in outpatient substance use disorder treatment episode completion for different substances. J. Subst. Abus. Treat.63, 25–33. doi: 10.1016/j.jsat.2015.12.007
149
MerkelS. F.CannellaL. A.RazmpourR.LuttonE.RaghupathiR.RawlsS. M.et al. (2017). Factors affecting increased risk for substance use disorders following traumatic brain injury: what we can learn from animal models. Neurosci. Biobehav. Rev.77, 209–218. doi: 10.1016/j.neubiorev.2017.03.015
150
MeyerJ. E.JammulaV.ArnettP. A. (2021). Head trauma in a community-based sample of victims of intimate partner violence: prevalence, mechanisms of injury and symptom presentation. J. Interpers. Violence37, NP15255–NP15274. doi: 10.1177/08862605211016362
151
MooreT. M.StuartG. L.MeehanJ. C.RhatiganD. L.HellmuthJ. C.KeenS. M. (2008). Drug abuse and aggression between intimate partners: a meta-analytic review. Clin. Psychol. Rev.28, 247–274. doi: 10.1016/j.cpr.2007.05.003
152
MueserK. T.NoordsyD. L.DrakeR. E.FoxL. (2003). Integrated Treatment for Dual Disorders: A Guide to Effective Practice. New York, NY: The Guilford Press.
153
MurphyC. M.TingL. (2010). The effects of treatment for substance use problems on intimate partner violence: a review of empirical data. Aggress. Violent Behav.15, 325–333. doi: 10.1016/j.avb.2010.01.006
154
NajavitsL. M. (2007). “7- seeking safety: an evidence-based model for substance abuse and trauma/PTSD” in Therapist’s Guide to Evidence-Based Relapse Prevention. eds. WitkiewitzK. A.MarlattG. A. (Cambridge, MA: Academic Press), 141–167.
155
NajavitsL. M.HienD. (2013). Helping vulnerable populations: a comprehensive review of the treatment outcome literature on substance use disorder and PTSD. J. Clin. Psychol.69, 433–479. doi: 10.1002/jclp.21980
156
NajavitsL. M.SonnJ.WalshM.WeissR. D. (2004). Domestic violence in women with PTSD and substance abuse. Addict. Behav.29, 707–715. doi: 10.1016/j.addbeh.2004.01.003
157
NanayakkaraB.McNamaraS. (2021). “Respiratory problems and substance misuse” in Textbook of Addiction Treatment: International Perspectives. eds. El-GuebalyN.CarràG.GalanterM.BaldacchinoA. M. (Cham: Springer International Publishing), 1045–1059. doi: 10.1007/978-3-030-36391-8_74
158
NathansonA. M.ShoreyR. C.TironeV.RhatiganD. L. (2012). The prevalence of mental health disorders in a community sample of female victims of intimate partner violence. Partn. Abus.3, 59–75. doi: 10.1891/1946-6560.3.1.59
159
National Institute of Justice (2016). Five Things About Violence Against American Indian and Alaska Native Women and Men. Washington, DC. U.S Department of Justice.
160
NeddenriepB.BagdasD.ContrerasK. M.DitreJ. W.WolstenholmeJ. T.MilesM. F.et al. (2019). Pharmacological mechanisms of alcohol analgesic-like properties in mouse models of acute and chronic pain. Neuropharmacology160:107793. doi: 10.1016/j.neuropharm.2019.107793
161
NikooM.GadermannA.To, M. JKrauszM.HwangS. W.PalepuA. (2017). Incidence and associated risk factors of traumatic brain injury in a cohort of homeless and vulnerably housed adults in 3 Canadian cities. J. Head Trauma Rehabil.32, E19–E26. doi: 10.1097/HTR.0000000000000262,
162
NiolonP. H.KearnsM.DillsJ.RamboK.IrviingS.ArmsteadT.et al. (2017). Preventing Intimate Partner Violence Across the Lifespan: A Technical Package of Programs, Policies, and Practices. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA.
163
NowotnyK. M.GravesJ. L. (2013). Substance use and intimate partner violence victimization among white, African American, and Latina women. J. Interpers. Violence28, 3301–3318. doi: 10.1177/0886260513496903
164
OakleyL. D.LuebkeJ.DoschN. C.SneddenT. R.HernadezH.LemkeM.et al. (2021). Traumatic brain injury screening and the unmet health needs of shelter-seeking women with head injuries related to intimate partner violence. Womens Health Rep (New Rochelle).2, 586–593. doi: 10.1089/whr.2021.0056
165
OgdenS. N.DichterM. E.BazziA. R. (2022). Intimate partner violence as a predictor of substance use outcomes among women: a systematic review. Addict. Behav.127:107214. doi: 10.1016/j.addbeh.2021.107214
166
OkudaM.OlfsonM.HasinD.GrantB. F.LinK.-H.BlancoC. (2011). Mental health of victims of intimate partner violence: results from a national epidemiologic survey. Psychiatr. Serv.62, 959–962. doi: 10.1176/ps.62.8.pss6208_0959
167
OliverioR.KarelinaK.WeilZ. M. (2020). Sex, drugs, and TBI: the role of sex in substance abuse related to traumatic brain injuries. Front. Neurol.11:546775. doi: 10.3389/fneur.2020.546775
168
OlsenC. M.CorriganJ. D. (2021). Does TBI cause risky substance use or substance use disorder?Biol. Psychiatry91, 421–437. doi: 10.1016/j.biopsych.2021.07.013
169
Olson-MaddenJ. H.BrennerL. A.CorriganJ. D.EmrickC. D.BrittonP. C. (2012). Substance use and mild traumatic brain injury risk reduction and prevention: a novel model for treatment. Rehabil. Res. Pract.2012:174579. doi: 10.1155/2012/174579
170
OramS.FisherH. L.MinnisH.SeedatS.WalbyS.HegartyK.et al. (2022). The lancet psychiatry commission on intimate partner violence and mental health: advancing mental health services, research, and policy. Lancet Psychiatry9, 487–524. doi: 10.1016/S2215-0366(22)00008-6
171
Otiniano VerissimoA. D.GeeG. C.FordC. L.IguchiM. Y. (2014). Racial discrimination, gender discrimination, and substance abuse among Latina/os nationwide. Cultur. Divers. Ethnic Minor. Psychol.20, 43–51. doi: 10.1037/a0034674
172
ØverupC. S.DiBelloA. M.BrunsonJ. A.AcitelliL. K.NeighborsC. (2015). Drowning the pain: intimate partner violence and drinking to cope prospectively predict problem drinking. Addict. Behav.41, 152–161. doi: 10.1016/j.addbeh.2014.10.006
173
OwensM. D.HallgrenK. A.LaddB. O.RynesK.McCradyB. S.EpsteinE. (2013). Associations between relationship satisfaction and drinking urges for women in alcohol behavioral couples and individual therapy. Alcohol. Treat. Q.31, 415–430. doi: 10.1080/07347324.2013.831668
174
PagulayanK. F.TemkinN. R.MachamerJ. E.DikmenS. S. (2016). Patterns of alcohol use after traumatic brain injury. J. Neurotrauma33, 1390–1396. doi: 10.1089/neu.2015.4071
175
PallatinoC.ChangJ. C.KransE. E. (2019). The intersection of intimate partner violence and substance use among women with opioid use disorder. Subst. Abus.42, 197–204. doi: 10.1080/08897077.2019.1671296
176
PaoneD.ChavkinW.WilletsI.FriedmannP.JarlaisD. D. (1992). The impact of sexual abuse: implications for drug treatment. J. Women's Health1, 149–153. doi: 10.1089/jwh.1992.1.149
177
PatelV.ChisholmD.ParikhR.CharlsonF. J.DegenhardtL.DuaT.et al. (2016). Addressing the burden of mental, neurological, and substance use disorders: key messages from disease control priorities. Lancet387, 1672–1685. doi: 10.1016/S0140-6736(15)00390-6
178
PatrickM. E.Evans-PolceR. J.ParksM. J.Terry-McElrathY. M. (2021). Drinking intensity at age 29/30 as a predictor of alcohol use disorder symptoms at age 35 in a National Sample. J. Stud. Alcohol Drugs82, 362–367. doi: 10.15288/jsad.2021.82.362
179
PeacockA.LeungJ.LarneyS.ColledgeS.HickmanM.RehmJ.et al. (2018). Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction113, 1905–1926. doi: 10.1111/add.14234
180
Pico-AlfonsoM. A. (2005). Psychological intimate partner violence: the major predictor of posttraumatic stress disorder in abused women. Neurosci. Biobehav. Rev.29, 181–193. doi: 10.1016/j.neubiorev.2004.08.010
181
PlummerS.-B.FindleyP. A. (2012). Women with disabilities’ experience with physical and sexual abuse: review of the literature and implications for the field. Trauma Violence Abuse13, 15–29. doi: 10.1177/1524838011426014
182
PonsfordJ.Whelan-GoodinsonR.Bahar-FuchsA. (2007). Alcohol and drug use following traumatic brain injury: a prospective study. Brain Inj.21, 1385–1392. doi: 10.1080/02699050701796960
183
PooleN.GreavesL.JategaonkarN.McCulloughL.ChabotC. (2008). Substance use by women using domestic violence shelters. Subst. Use Misuse43, 1129–1150. doi: 10.1080/10826080801914360
184
PriesterM. A.BrowneT.IachiniA.CloneS.DeHartD.SeayK. D. (2016). Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J. Subst. Abus. Treat.61, 47–59. doi: 10.1016/j.jsat.2015.09.006
185
ProG.SahkerE.MarzellM. (2018). Microaggressions and marijuana use among college students. J. Ethn. Subst. Abus.17, 375–387. doi: 10.1080/15332640.2017.1288191
186
RabinR. F.JenningsJ. M.CampbellJ. C.Bair-MerrittM. H. (2009). Intimate partner violence screening tools: a systematic review. Am. J. Prev. Med.36, 439–445.e4. doi: 10.1016/j.amepre.2009.01.024
187
RadcliffeP.GilchristG. (2016). “You can never work with addictions in isolation”: addressing intimate partner violence perpetration by men in substance misuse treatment. Int. J. Drug Policy36, 130–140. doi: 10.1016/j.drugpo.2016.03.010
188
RaithK.HochhausG. (2004). Drugs used in the treatment of opioid tolerance and physical dependence: a review. Int. J. Clin. Pharmacol. Ther.42, 191–203. doi: 10.5414/cpp42191
189
RasmussenV.SteelZ.SpangaroJ.TorokM. (2021). Investigating the prevalence of intimate partner violence victimisation in women presenting to the emergency department in suicidal crisis. Emerg. Med. Australas.33, 703–710. doi: 10.1111/1742-6723.13714
190
ReingleJ. M.StarasS. A. S.JenningsW. G.BranchiniJ.Maldonado-MolinaM. M. (2012). The relationship between marijuana use and intimate partner violence in a nationally representative, longitudinal sample. J. Interpers. Violence27, 1562–1578. doi: 10.1177/0886260511425787
191
RhodesK. V.KothariC. L.DichterM.CerulliC.WileyJ.MarcusS. (2011). Intimate partner violence identification and response: time for a change in strategy. J. Gen. Intern. Med.26, 894–899. doi: 10.1007/s11606-011-1662-4
192
RogozeaL.DinuE. A.ConstantinD.LeaşuF.-G. (2020). Self-medicating for pain: a public health perspective. Am. J. Ther.27, e387–e391. doi: 10.1097/MJT.0000000000001173
193
RolleroC.SperanzaF. (2020). Intimate partner violence and resilience: the experience of women in mother-Child assisted living centers. Int. J. Environ. Res. Public Health17:8318. doi: 10.3390/ijerph17228318
194
RosayA. (2016). Violence Against American Indian and Alaska Native Women and Men. NIJ Journal277, 38–45.
195
RussoE. B.GuyG. W.RobsonP. J. (2007). Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex®, a cannabis-based medicine. Chem. Biodivers.4, 1729–1743. doi: 10.1002/cbdv.200790150
196
SaleemG. T.FitzpatrickJ. M.HaiderM. N.ValeraE. M. (2021). COVID-19-induced surge in the severity of gender-based violence might increase the risk for acquired brain injuries. SAGE Open Med.9:20503121211050196. doi: 10.1177/20503121211050197
197
SalomC. L.WilliamsG. M.NajmanJ. M.AlatiR. (2015). Substance use and mental health disorders are linked to different forms of intimate partner violence victimisation. Drug Alcohol Depend.151, 121–127. doi: 10.1016/j.drugalcdep.2015.03.011
198
SaniA. I.PereiraD. (2020). Mothers as victims of intimate partner violence: the decision to leave or stay and resilience-oriented intervention. Soc. Sci.9:174. doi: 10.3390/socsci9100174
199
SaundersJ. B.AaslandO. G.BaborT. F.de la FuenteJ. R.GrantM. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II. Addiction88, 791–804. doi: 10.1111/j.1360-0443.1993.tb02093.x
200
SchaeferL. M.HowellK. H.SheddanH. C.NapierT. R.ShoemakerH. L.Miller-GraffL. E. (2021). The road to resilience: strength and coping among pregnant women exposed to intimate partner violence. J. Interpers. Violence36, 8382–8408. doi: 10.1177/0886260519850538
201
SchindlerA. G.BaskinB.JuarezB.Janet LeeS.HendricksonR.PagulayanK.et al. (2021). Repetitive blast mild traumatic brain injury increases ethanol sensitivity in male mice and risky drinking behavior in male combat veterans. Alcohol. Clin. Exp. Res.45, 1051–1064. doi: 10.1111/acer.14605
202
SchmidtL. A.YeY.GreenfieldT. K.BondJ. (2007). Ethnic disparities in clinical severity and services for alcohol problems: results from the National Alcohol Survey. Alcohol. Clin. Exp. Res.31, 48–56. doi: 10.1111/j.1530-0277.2006.00263.x
203
SchneiderR.BurnetteM. L.IlgenM. A.TimkoC. (2009). Prevalence and correlates of intimate partner violence victimization among men and women entering substance use disorder treatment. Violence Vict.24, 744–756. doi: 10.1891/0886-6708.24.6.744
204
SheridanD. J.NashK. R. (2007). Acute injury patterns of intimate partner violence victims. Trauma Violence Abuse8, 281–289. doi: 10.1177/1524838007303504
205
ShiwalkarN.GregorD.FuR.BekkerA.Hong YeJ. (2017). Changes in alcohol-related behavior following an incident of traumatic brain injury. J. Trauma Treat.6, 1–7. doi: 10.4172/2167-1222.1000392
206
SimmonsC. A.DelaneyM. J.LindseyL.WhalleyA.Murry-DrobotO.Gayle BeckJ. (2017). Should programs designed to help IPV survivors screen for mental health-related problems: voices from the Field. Violence Against Women23, 603–622. doi: 10.1177/1077801216646225
207
SimmonsC. A.WhalleyA.BeckJ. G. (2014). Use of mental health screening instruments by non-medical helping professionals: a needs assessment. J. Interpers. Violence. 29, 2068–2090. doi: 10.1177/0886260513516386
208
SimonelliA.PasqualiC. E.De PaloF. (2014). Intimate partner violence and drug-addicted women: from explicative models to gender-oriented treatments. Eur. J. Psychotraumatol.5:24496. doi: 10.3402/ejpt.v5.24496
209
SkinnerH. A. (1982). The drug abuse screening test. Addict. Behav.7, 363–371. doi: 10.1016/0306-4603(82)90005-3
210
SmedleyB. D.StithA. Y.NelsonA. R. (2003). Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press.
211
SmithP. H.HomishG. G.LeonardK. E.CorneliusJ. R. (2012). Intimate partner violence and specific substance use disorders: findings from the National Epidemiologic Survey on alcohol and related conditions. Psychol. Addict. Behav.26, 236–245. doi: 10.1037/a0024855
212
SmithS. G.ZhangX.BasileK. C.MerrickM. T.WangJ.KresnowM.et al. (2018). The National Intimate Partner and sexual violence survey: 2015 data brief — Updated release. Atlanta, GA: National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.
213
St IvanyA.SchminkeyD. (2016). Intimate partner violence and traumatic brain injury: state of the science and next steps. Fam. Community Health39, 129–137. doi: 10.1097/FCH.0000000000000094
214
SteneL. E.DybG.TverdalA.JacobsenG. W.ScheiB. (2012). Intimate partner violence and prescription of potentially addictive drugs: prospective cohort study of women in the Oslo health study. BMJ Open2:e000614. doi: 10.1136/bmjopen-2011-000614
215
StoicescuC.AmeiliaR.IrwantoPraptoraharjoI.MahananiM. (2019). Syndemic and synergistic effects of intimate partner violence, crystal methamphetamine, and depression on HIV sexual risk behaviors among women who inject drugs in Indonesia. J. Urban Health96, 477–496. doi: 10.1007/s11524-019-00352-6
216
StoneR.RothmanE. F. (2019). Opioid use and intimate partner violence: a systematic review. Curr. Epidemiol. Rep.6, 215–230. doi: 10.1007/s40471-019-00197-2
217
SullivanT. P.AshareR. L.JaquierV.TennenH. (2012). Risk factors for alcohol-related problems among victims of partner violence. Subst. Use Misuse47, 673–685. doi: 10.3109/10826084.2012.658132
218
SullivanT. P.HoltL. J. (2008). PTSD symptom clusters are differentially related to substance use among community women exposed to intimate partner violence. J. Trauma. Stress.21, 173–180. doi: 10.1002/jts.20318
219
SullivanT. P.WeissN. H.FlanaganJ. C.WillieT. C.ArmeliS.TennenH. (2016). PTSD and daily co-occurrence of drug and alcohol use among women experiencing intimate partner violence. J. Dual Diagn.12, 36–42. doi: 10.1080/15504263.2016.1146516
220
TestaM.LeonardK. E. (2001). The impact of marital aggression on Women’s psychological and marital functioning in a newlywed sample. J. Fam. Violence16, 115–130. doi: 10.1023/A:1011154818394
221
TestaM.LivingstonJ. A.LeonardK. E. (2003). Women’s substance use and experiences of intimate partner violence: a longitudinal investigation among a community sample. Addict. Behav.28, 1649–1664. doi: 10.1016/j.addbeh.2003.08.040
222
ThompsonT.OramC.CorrellC. U.TsermentseliS.StubbsB. (2017). Analgesic effects of alcohol: a systematic review and meta-analysis of controlled experimental studies in healthy participants. J. Pain18, 499–510. doi: 10.1016/j.jpain.2016.11.009
223
TimkoC.FinneyJ. W.MoosR. H. (2005). The 8-year course of alcohol abuse: gender differences in social context and coping. Alcohol. Clin. Exp. Res.29, 612–621. doi: 10.1097/01.ALC.0000158832.07705.22
224
TolW. A.MurrayS. M.LundC.BoltonP.MurrayL. K.DaviesT.et al. (2019). Can mental health treatments help prevent or reduce intimate partner violence in low-and middle-income countries? A systematic review. BMC Women’s Health19:34. doi: 10.1186/s12905-019-0728-z
225
TsirigotisK.ŁuczakJ. (2018). Resilience in women who experience domestic violence. Psychiatry Q.89, 201–211. doi: 10.1007/s11126-017-9529-4
226
UllmanS. E.SigurvinsdottirR. (2015). Intimate partner violence and drinking among victims of adult sexual assault. J. Aggress. Maltreat. Trauma24, 117–130. doi: 10.1080/10926771.2015.996312
227
USDHHS (2020). Understanding Substance Use Coercion as a Barrier to Economic Stability for Survivors of Intimate Partner Violence: Policy Implications. Office of the Assistant Secretary for Planning and Evaluation and the Family and Youth Services Bureau, Division of Family Violence Prevention and Services, Washington, DC.
228
ValeraE. M.BerenbaumH. (2003). Brain injury in battered women. J. Consult. Clin. Psychol.71, 797–804. doi: 10.1037/0022-006X.71.4.797
229
ValeraE. M.CaoA.PasternakO.ShentonM. E.KubickiM.MakrisN.et al. (2019). White matter correlates of mild traumatic brain injuries in women subjected to intimate-partner violence: a preliminary study. J. Neurotrauma36, 661–668. doi: 10.1089/neu.2018.5734
230
ValeraE. M.DaughertyJ. C.ScottO. C.BerenbaumH. (2022). Strangulation as an acquired brain injury in intimate-partner violence and its relationship to cognitive and psychological functioning: a preliminary study. J. Head Trauma Rehabil.37, 15–23. doi: 10.1097/HTR.0000000000000755
231
ValeraE.KucyiA. (2017). Brain injury in women experiencing intimate partner-violence: neural mechanistic evidence of an “invisible” trauma. Brain Imaging Behav.11, 1664–1677. doi: 10.1007/s11682-016-9643-1
232
VolkowN. D.JonesE. B.EinsteinE. B.WargoE. M. (2019). Prevention and treatment of opioid misuse and addiction: a review. JAMA Psychiat.76, 208–216. doi: 10.1001/jamapsychiatry.2018.3126
233
VoonP.GreerA. M.AmlaniA.NewmanC.BurmeisterC.BuxtonJ. A. (2018). Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada. Harm. Reduct. J.15:35. doi: 10.1186/s12954-018-0241-y
234
Voth SchragR. (2017). Campus based sexual assault and dating violence: a review of study contexts and participants. Affilia32, 67–80. doi: 10.1177/0886109916644644
235
VungkhanchingM.HeinemannA. W.LangleyM. J.RidgelyM.KramerK. M. (2007). Feasibility of a skills-based substance abuse prevention program following traumatic brain injury. J. Head Trauma Rehabil.22, 167–176. doi: 10.1097/01.HTR.0000271117.19652.98
236
WaalenJ.GoodwinM. M.SpitzA. M.PetersenR.SaltzmanL. E. (2000). Screening for intimate partner violence by health care providers: barriers and interventions. Am. J. Prev. Med.19, 230–237. doi: 10.1016/S0749-3797(00)00229-4
237
WagnerK. D.HudsonS. M.LatkaM. H.StrathdeeS. A.ThiedeH.Mackesy-AmitiM. E.et al. (2009). The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav.13, 217–224. doi: 10.1007/s10461-007-9309-5
238
WalkerN.BeekK.ChenH.ShangJ.StevensonS.WilliamsK.et al. (2022). The experiences of persistent pain among women with a history of intimate partner violence: a systematic review. Trauma Violence Abuse23, 490–505. doi: 10.1177/1524838020957989
239
WarsawC.TinnonE. (2018). Coercion Related to Mental Health and Substance Use in the Context of Intimate Partner Violence: a Toolkit for Screening, Assessment, and Brief Counseling in Primary Care and Behavioral Health Settings. Chicago IL, USA: National Center on Domestic Violence, Trauma, & Mental Health.
240
WeilZ. M.CorriganJ. D.KarelinaK. (2016). Alcohol abuse after traumatic brain injury: experimental and clinical evidence. Neurosci. Biobehav. Rev.62, 89–99. doi: 10.1016/j.neubiorev.2016.01.005
241
WeinsheimerR. L.SchermerC. R.MalcoeL. H.BaldufL. M.BloomfieldL. A. (2005). Severe intimate partner violence and alcohol use among female trauma patients. J. Trauma58, 22–29. doi: 10.1097/01.ta.0000151180.77168.a6
242
Werner-WilsonR. J.ZimmermanT. S.WhalenD. (2000). Resilient response to battering. Contemp. Fam. Ther.22, 161–188. doi: 10.1023/A:1007777702757
243
WHO. (2013). Global and regional estimates of violence against women: Prevalence and health effects of intimate partner violence and non-partner sexual violence. Geneva: World Health Organization.
244
WHO (2021). Violence Against Women Prevalence Estimates. Geneva: WHO.
245
WilburL.HigleyM.HatfieldJ.SurprenantZ.TaliaferroE.SmithD. J.et al. (2001). Survey results of women who have been strangled while in an abusive relationship. J. Emerg. Med.21, 297–302. doi: 10.1016/s0736-4679(01)00398-5
246
WilliamsJ. R.GirdlerS.WilliamsW.CromeensM. G. (2020). The effects of co-occurring interpersonal trauma and gender on opioid use and misuse. J. Interpers. Violence36, NP13185–NP13205. doi: 10.1177/0886260519900309
247
WoodsS. J.HallR. J.CampbellJ. C.AngottD. M. (2008). Physical health and posttraumatic stress disorder symptoms in women experiencing intimate partner violence. J. Midwifery Womens Health53, 538–546. doi: 10.1016/j.jmwh.2008.07.004
248
WuestJ.Ford-GilboeM.Merritt-GrayM.WilkP.CampbellJ. C.LentB.et al. (2010). Pathways of chronic pain in survivors of intimate partner violence. J. Women's Health19, 1665–1674. doi: 10.1089/jwh.2009.1856
249
WuestJ.Merritt-GrayM.Ford-GilboeM.LentB.VarcoeC.CampbellJ. C. (2008). Chronic pain in women survivors of intimate partner violence. J. Pain9, 1049–1057. doi: 10.1016/j.jpain.2008.06.009
250
YamashitaA.YoshiokaS.YajimaY. (2021). Resilience and related factors as predictors of relapse risk in patients with substance use disorder: a cross-sectional study. Subst. Abuse Treat. Prev. Policy16:40. doi: 10.1186/s13011-021-00377-8
251
YooH. C.GeeG. C.LowthropC. K.RobertsonJ. (2010). Self-reported racial discrimination and substance use among Asian Americans in Arizona. J. Immigr. Minor. Health12, 683–690. doi: 10.1007/s10903-009-9306-z
252
YoungerJ.BarelkaP.CarrollI.KaplanK.ChuL.PrasadR.et al. (2008). Reduced cold pain tolerance in chronic pain patients following opioid detoxification. Pain Med.9, 1158–1163. doi: 10.1111/j.1526-4637.2008.00475.x
253
ZiemanG.BridwellA.CárdenasJ. F. (2017). Traumatic brain injury in domestic violence victims: a retrospective study at the Barrow neurological institute. J. Neurotrauma34, 876–880. doi: 10.1089/neu.2016.4579
Summary
Keywords
substance misuse, interpersonal violence, brain injury, resilience, mood disorders
Citation
Mehr JB, Bennett ER, Price JL, de Souza NL, Buckman JF, Wilde EA, Tate DF, Marshall AD, Dams-O'Connor K and Esopenko C (2023) Intimate partner violence, substance use, and health comorbidities among women: A narrative review. Front. Psychol. 13:1028375. doi: 10.3389/fpsyg.2022.1028375
Received
25 August 2022
Accepted
14 December 2022
Published
27 January 2023
Volume
13 - 2022
Edited by
Andrea Poli, University of Pisa, Italy
Reviewed by
Glenna Tinney, Consultant, Alexandria, VA, United States; Gwen Hunnicutt, University of North Carolina at Greensboro, United States
Updates
Copyright
© 2023 Mehr, Bennett, Price, De Souza, Buckman, Wilde, Tate, Marshall, Dams-O'Connor and Esopenko.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Carrie Esopenko, Carrie.Esopenko@mountsinai.org
†These authors share first authorship
This article was submitted to Psychology for Clinical Settings, a section of the journal Frontiers in Psychology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.